Author:
de Mello Sampayo Felipa,Fiuza Manuela,Pinto Fausto,Fontes Joana
Reference29 articles.
1. Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease;Drafts;JACC: Cardiovasc Imag,2013
2. Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials;Swain;Cancer,2003
3. Cost-effectiveness of cardiotoxicity monitoring;Yu,2017
4. Cardiac toxicity 4 to 20 years after completing anthracycline therapy;Steinherz;JAMA,1991
5. Major cardiac events and the value of echocardiographic evaluation in patients receiving anthracycline-based chemotherapy;Wang;Am J Cardiol,2015